BiotechTube
Home/Coya Therapeutics/Dr. Arun Swaminathan
DA

Dr. Arun Swaminathan

Chief Executive Officer

Coya Therapeutics

Therapeutic Areas

Neurodegenerative DiseasesAutoimmune DisordersMetabolic Diseases

Coya Therapeutics Pipeline

DrugIndicationPhase
COYA 302Amyotrophic Lateral Sclerosis (ALS)Phase 2
COYA 201Undisclosed Inflammatory IndicationsPreclinical
COYA 101Undisclosed Autoimmune IndicationsPreclinical

Leadership Team at Coya Therapeutics

DH
Dr. Howard Berman
Executive Chairman of the Board
DS
Dr. Stanley H. Appel
Co-founder and Chairman Emeritus
DF
Dr. Fred Grossman
Chief Medical Officer
AM
Ann Maurer
Chief Financial Officer
View full Coya Therapeutics profile